| |
| |
|
| Insider
Information: |
Conrad Herbert J |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
67,001 |
|
|
Indirect Shares
|
4,694,566 |
|
|
| Direct
Value |
$1,282,050 |
|
|
|
Indirect Value
|
$768,500 |
|
|
| Total
Shares |
4,761,567 |
|
|
| Total
Value |
$2,050,550 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 38.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2010-06-08 |
28,501 |
2003-06-30 |
0 |
Premium* |
|
|
Celldex Therapeutics Inc |
CLDX |
Director |
2017-06-15 |
38,500 |
2009-12-23 |
0 |
Premium* |
|
|
Matinas Biopharma Holdings, Inc. |
MTNB |
Director |
2021-08-04 |
0 |
2022-06-22 |
4,694,566 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-10-03 |
4 |
OE |
$7.88 |
$19,688 |
D/D |
2,500 |
28,417 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-10-08 |
4 |
OE |
$7.41 |
$35,281 |
D/D |
4,629 |
28,417 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-11-28 |
4 |
OE |
$11.81 |
$29,533 |
D/D |
2,500 |
28,417 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-11-29 |
4 |
OE |
$12.74 |
$31,850 |
D/D |
2,500 |
28,417 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
28,500 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2010-06-08 |
4 |
A |
$11.38 |
$39,989 |
D/D |
3,514 |
28,501 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-10-05 |
4 |
OE |
$7.88 |
$22,609 |
D/D |
2,871 |
28,788 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-10-09 |
4 |
OE |
$7.41 |
$37,030 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-10-10 |
4 |
OE |
$11.81 |
$59,065 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-11-30 |
4 |
OE |
$12.74 |
$63,700 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-01-02 |
4 |
OE |
$2.96 |
$14,800 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-01-03 |
4 |
OE |
$3.20 |
$16,005 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-02-01 |
4 |
OE |
$2.70 |
$13,500 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-02-04 |
4 |
OE |
$4.67 |
$23,350 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-03-03 |
4 |
OE |
$5.05 |
$25,250 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-03-04 |
4 |
OE |
$4.61 |
$23,050 |
D/D |
5,000 |
30,917 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
38,500 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,932,903 |
100,000 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22,019 |
122,019 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2020-06-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,639,039 |
125,000 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-05-16 |
4 |
B |
$0.96 |
$24,115 |
I/I |
25,000 |
172,959 |
2.1 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2021-01-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
175,000 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
28,005 |
197,983 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
397,983 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
48,000 |
445,983 |
0 |
- |
|
96 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
